{"id":"elocon-0-1-topical-cream","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin atrophy"},{"rate":null,"effect":"Striae"},{"rate":null,"effect":"Telangiectasia"},{"rate":null,"effect":"Local irritation or burning"},{"rate":null,"effect":"Folliculitis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Mometasone furoate binds to glucocorticoid receptors in skin cells, inhibiting the production of inflammatory mediators such as cytokines and prostaglandins. This reduces erythema, pruritus, and other signs of inflammation in dermatological conditions. As a potent topical steroid, it has both anti-inflammatory and immunosuppressive effects localized to the site of application.","oneSentence":"Mometasone furoate is a topical corticosteroid that reduces inflammation and suppresses immune responses in the skin.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:29:07.661Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, psoriasis, dermatitis)"},{"name":"Atopic dermatitis"},{"name":"Contact dermatitis"}]},"trialDetails":[{"nctId":"NCT07311759","phase":"PHASE3","title":"Safety and Efficacy of Intralesional 0.5% Triamcinolone Acetonide in 0.2% Fluconazole Solution vs 0.1% Topical Mometasone Furoate With 2% Miconazole Nitrate Cream in the Treatment of Chronic Paronychia: An Intraindividual Randomized Controlled Trial.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2024-08-17","conditions":"Chronic Paronychia","enrollment":21},{"nctId":"NCT06636240","phase":"NA","title":"Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic Dermatitis","status":"RECRUITING","sponsor":"Taipei Medical University Shuang Ho Hospital","startDate":"2025-03-17","conditions":"Atopic Dermatitis (Eczema), Atopic Dermatitis, Probiotics","enrollment":120},{"nctId":"NCT05505214","phase":"PHASE2","title":"Topical Steroids & Bacterial Decolonization for Radiation Dermatitis","status":"WITHDRAWN","sponsor":"Montefiore Medical Center","startDate":"2023-09-01","conditions":"Radiation Dermatitis","enrollment":""},{"nctId":"NCT05578482","phase":"PHASE4","title":"Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis","status":"UNKNOWN","sponsor":"Jacob Pontoppidan Thyssen","startDate":"2022-10-24","conditions":"Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis Flare","enrollment":45},{"nctId":"NCT05228483","phase":"NA","title":"Carbon Dioxide（CO2）Fractional Laser Plus Photodynamic Therapy in Female Patients With Vulvar Lichen Sclerosus","status":"UNKNOWN","sponsor":"Xijing Hospital","startDate":"2021-11-23","conditions":"Vulva Lichen Sclerosus","enrollment":134},{"nctId":"NCT01856543","phase":"PHASE3","title":"Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2013-05","conditions":"Invasive Breast Cancer","enrollment":143},{"nctId":"NCT00721331","phase":"PHASE1","title":"A Phase I Study to Assess the Safety and Tolerability of Topical CRx-197 Formulations in Healthy Volunteers","status":"COMPLETED","sponsor":"Zalicus","startDate":"2008-07","conditions":"Atopic Dermatitis","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Mometasone furoate 0.1%"],"phase":"marketed","status":"active","brandName":"Elocon 0.1 % Topical Cream","genericName":"Elocon 0.1 % Topical Cream","companyName":"Jacob Pontoppidan Thyssen","companyId":"jacob-pontoppidan-thyssen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Mometasone furoate is a topical corticosteroid that reduces inflammation and suppresses immune responses in the skin. Used for Inflammatory and pruritic dermatoses responsive to topical corticosteroids (e.g., eczema, psoriasis, dermatitis), Atopic dermatitis, Contact dermatitis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}